Browsing by Author Abenavoli L.
Showing results 1 to 20 of 33
next >
Issue Date | Title | Author(s) |
---|---|---|
1-Jan-2015 | Adiponectin serum level in chronic hepatitis C infection and therapeutic profile | Peta V.; Torti C.; Milić, Nataša ; Focà A.; Abenavoli L. |
1-Jan-2014 | Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet | Abenavoli L.; Milić N. ; Peta V.; Alfieri F.; De Lorenzo A.; Bellentani S. |
1-Dec-2012 | Anti-oxidant therapy in non-alcoholic fatty liver disease: The role of silymarin | Abenavoli L.; Milić, Nataša ; Capasso F. |
1-Nov-2013 | Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori | Abenavoli L.; Milić, Nataša ; Masarone M.; Persico M. |
1-Jan-2017 | Celiac disease and hearing loss | Lemajić Komazec, Slobodanka ; Abenavoli L. |
1-Feb-2013 | Dietary Intervention in Non-Alcoholic Fatty Liver Disease | Abenavoli L.; Milić, Nataša |
12-Aug-2017 | Effect of mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: A randomized study | Abenavoli L.; Greco M.; Milić, Nataša ; Accattato F.; Foti D.; Gulletta E.; Luzza F. |
1-Apr-2015 | Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease | Abenavoli L.; Greco M.; Nazionale I.; Peta V.; Milić, Nataša ; Accattato F.; Foti D.; Gulletta E.; Luzza F. |
2-Sep-2017 | Gut microbiota changes and chronic hepatitis C virus infection | Preveden, Andrej; Scarpellini E.; Milić, Nataša ; Luzza F.; Abenavoli L. |
1-Jan-2012 | Haemophagocytic syndrome associated with mucormycosis infection | Arena V.; De-Giorgio F.; Pennacchia I.; Manna R.; Vetrugno G.; Stigliano E.; Milić, Nataša ; Gasbarrini G.; Abenavoli L. |
1-Dec-2018 | Hepatitis C virus-induced hepatocellular carcinoma: A narrative review | Ružić, Maja ; Pellicano R.; Fabri M.; Luzza F.; Boccuto L.; Brkić, Miodrag; Abenavoli L. |
1-Mar-2017 | The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders | Medić Stojanoska, Milica ; Milošević, Nataša; Milić, Neda; Abenavoli L. |
1-Jan-2014 | Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 | Abenavoli L.; Masarone M.; Peta V.; Milić, Nataša ; Kobyliak N.; Rouabhia S.; Persico M. |
1-Oct-2018 | Iron deficiency anemia and hearing loss | Lemajić Komazec, Slobodanka ; Abenavoli L. |
1-Jan-2015 | Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: A case series | Abenavoli L.; Peta V.; Milić, Nataša |
1-Mar-2013 | Liver steatosis in celiac disease: The open door | Abenavoli L.; Luigiano C.; Larussa T.; Milić, Nataša ; De Lorenzo A.; Stelitano L.; Morace C.; Consolo P.; Miraglia S.; Fagoonee S.; Virgilio C.; Luzza F.; Pellicano R. |
1-Jan-2014 | Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease | Abenavoli L.; Milić, Nataša ; Luigiano C. |
21-Aug-2016 | Metabolic aspects of adult patients with nonalcoholic fatty liver disease | Abenavoli L.; Milić, Neda; Di Renzo L.; Preveden, Andrej; Medić Stojanoska, Milica ; De Lorenzo A. |
1-Jan-2014 | Metformin in the treatment of non-alcoholic fatty liver disease: Safety, efficacy and mechanism | Rouabhia S.; Milić, Nataša ; Abenavoli L. |
1-Nov-2018 | Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases | Abenavoli L.; Izzo A.; Milić, Nataša ; Cicala C.; Santini A.; Capasso R. |